Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 456.63 | N/A |
| PEG Ratio (TTM) | 3.11 | N/A |
| P/S Ratio (TTM) | 0.83 | N/A |
| P/B Ratio (TTM) | 1.92 | N/A |
| P/FCF Ratio (TTM) | 81.89 | N/A |
| Price to 5YR AVG Earnings Ratio | 39.01 | N/A |
| Price to 5YR AVG FCF Ratio | 26.01 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.19% | N/A |
| ROE (TTM) | 0.43% | N/A |
| Net Profit Margin (TTM) | 0.18% | N/A |
| ROIC 5YR AVG | 12.48% | N/A |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 29.81% | 346.09% | 158.40% |
| Revenue | 5.60% | 26.23% | 12.94% |
| Net Income | 29.39% | 350.56% | 161.70% |
| Cash Flow | 6.41% | 88.66% | 75.21% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.75 | N/A |
| Quick Ratio (TTM) | 1.63 | N/A |
| D/E Ratio (TTM) | 0.57 | N/A |
| Interest Coverage (TTM) | 1.44 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.75 | N/A |
| LTL to 5YR AVG FCF | 9.55 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.13% | N/A |